Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
fda
3
×
life sciences
national blog main
san francisco blog main
3
×
san francisco top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
startups
abbvie
akouos
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
ashley mcevoy
astrazeneca
auris health
biogen
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
What
deal
3
×
developer
plans
acquiring
acquisitions
announced
auris
billion
bio
building
builds
buy
cash
ceo
collabs
company’s
covid
daniel
disease
drug
established
firm
gilead
gilead’s
health
help
introduce
ipo
johnson
lung
medical
medicines
momentum
month
o’day
pah
rare
reaches
rivalry
robotics
Language
unset
Current search:
deal
×
fda
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
